Feb 14 (Reuters) - InMed Pharmaceuticals Inc IN.TO :
* INMED PHARMACEUTICALS REPORTS SECOND QUARTER FISCAL 2020 FINANCIAL RESULTS AND PROVIDES RESEARCH AND DEVELOPMENT AND BUSINESS UPDATE
* Q2 LOSS PER SHARE C$0.02
* ANTICIPATE FILING A CTA FOR A SECOND PHASE 1 TRIAL, 755-102-HV, IN CURRENT CALENDAR QUARTER